Immune Responses Against the Myelin/Oligodendrocyte Glycoprotein in Experimental Autoimmune Demyelination

Lassmann H, Suchanek G, Ozawa K: Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis. Ann Neurol 36 (Suppl):S42-S46, 1994 Raine C: The neuropathology of multiple sclerosis. In Multiple Sclerosis: Clinical and Pathogenetic Basis, C Raine, H McFarlandand, W Tourtellotte (eds). London, Chapman & Hall, 1997, pp 151-171 Trapp B, Peterson J, Ransohoff R, Rudick R, Mork S, Bo L: Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285, 1998 Hohlfeld R: Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives. Brain 120:865-916, 1997 Tabira T, Kira J-I: Strain and species differences of encephalitogenic determinants of myelin basic protein and proteolipid apoprotein. In Myelin: Biology and Chemistry, RE Martenson (ed). Boca Raton, FL, CRC Press, 1992, pp 783-799 Sobel RA, Greer JM, Kuchroo VK: Minireview: Autoimmune responses to myelin proteolipid protein. Neurochem Res 19:915-921, 1994 Paterson PY: Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med 111:119-135, 1960 Zamvil SS, Steinman L: The T-lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579-621, 1990 Martin R, McFarland, HF, McFarlin DE: Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187, 1992 Brosnan CF, Raine CS: Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6:243-257, 1996 Weinstock-Guttman B, Ransohoff R, Kinkel R, Rudick R: The interferons: Biological effects, mechanisms of action, and use in multiple sclerosis. Ann Neurol 37:7-15 1995 Lucchinetti C, Bruck W, Rodriguez M, Lassmann H: Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 6:259-274, 1996 Lassmann H: Neuropathology in multiple sclerosis: New concepts. Multiple Sclerosis 4:93-98, 1998 Wekerle H, Kojima K, Lannes-Vierra J, Lassmann H, Linington C: Animal models. Ann Neurol 36:S47-S53, 1994 Bornstein M, Appel S: The application of tissue culture to the study of experimental “allergic” encephalomyelitis. I. Patterns of demyelination. J Neuropathol Exp Neurol 20:141-147, 1964 Brosnan CF, Stoner GL, Bloom BR, Wisniewski HM: Studies on demyelination by activated lymphocytes in the rabbit eye. II. Antibody-dependent cell-mediated demyelination. J Immunol 118:2103-2109, 1977 Seil FJ, Falk GA, Kies MW, Alvord EC: The in vitro demyelinating activity of sera from guinea pigs sensitized with whole CNS and with purified encephalitogen. Exp Neurol 22:545-555, 1968 Raine CS, Hummelgard A, Swanson E, Bornstein MB: Multiple sclerosis: Serum-induced demyelination in vitro. A light and electron microscope study. J Neurol Sci 20:127-148, 1973 Lebar R, Boutry JM, Vincent C, Robineaux R, Voisin G: Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties, and specificities of the serum-demyelinating factor. J Immunol 116:1439-1446, 1976 Lebar R, Vincent C: Tentative identification of a second central nervous system Myelin membrane autoantigen (M2) by a biochemical comparison with the basic protein (BP). J Neuroimmunol 1:367-389, 1981 Lebar R, Lubetzki C, Vincent C, Lombrail P, Boutry J-M: The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane. Clin Exp Immunol 66: 423-443, 1986 Linington C, Webb M, Woodhams PL: A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 6:387-396, 1984 Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu H-C, Lassmann H, Wekerle H: T cells specific for the myelin oligodendrocyte glycoprotein, mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23:1364-1373, 1993 Kerlero de Rosbo N, Honegger P, Lassmann H, Matthieu J-M: Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein. J Neurochem 55:583-587, 1990 Schluesener HJ, Sobel RA, Linington C, Weiner HL: A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139:4016-4021, 1987 Linington C, Lassmann H: Antibody responses in chronic relapsing experimental allergic encephalomyelitis: Correlation of serum demyelinating activity with antibody titre to the myelin/oligodendrocyte glycoprotein (MOG). J Neuroimmunol 17:61-69, 1987 Linington C, Bradl M, Lassmann H, Brunner C, Vass K: Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am J Pathol 130:443-454, 1988 Linington C, Engelhardt B, Kapocs G, Lassman H: Induction of persistently demyelinated lesions in the rat following the repeated adoptive transfer of encephalitogenic T cells and demyelinating antibody. J Neuroimmunol 40:219-224, 1992 Lassmann H, Brunner C, Bradl M, Linington C: Experimental allergic encephalomyelitis: The balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol (Berl) 75:566-576, 1988 Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL: Antibody facilitation of multiple sclerosis-like lesions in a non human primate. J Clin Invest 96:2966-2974, 1995 Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CCA, Ben-Nun A: Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 92:2602-2608, 1993 Diaz-Villoslada P, Shih A, Shao L, Genain C, Hauser S: T-cell reactivity to myelin antigens: Myelin/oligodendrocyte glycoprotein is a prevalent antigen. J Neuroimmunol 99:36-43, 1999 Lindert R, Haase C, Brehm U, Linington C, Wekerle H, Hohlfeld R: Multiple sclerosis: B-and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein. Brain 122: 2089-2100, 1999 Genain C, Cannella B, Hauser S, Raine C: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med 5:170-175, 1999 Raine C, Cannella B, Hauser S, Genain C: Demyelination in non-human primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: A case for antigen-specific antibody mediation. Ann Neurol 46:144-160, 1999 Pham-Dinh D, Allinquant B, Ruberg M, Della-Gaspera B, Nussbaum JL, Dautigny A: Characterization and expression of the cDNA coding for the human myelin/oligodendrocyte glycoprotein. J Neurochem 63:2353-2356, 1994 Hilton A, Slavin A, Hilton D, Bernard C: Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J Neurochem 65:309-318, 1995 Roth M, Malfroy L, Offer C, Sevin J, Enault G, Borot N, Pontarotti P, Coppin H: The human myelin oligodendrocyte glycoprotein (MOG) gene: Complete nucleotide sequence and structural characterization. Genomics 28:241-250, 1995 Gardinier MV, Amiguet P, Linington C, Matthieu JM: Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 33:177-187, 1992 Daubas P, Pham-Dinh D, Dautigny A: Structure and polymorphism of the mouse oligodendrocyte glycoprotein gene. Genomics 23:36-41, 1994 Pham-Dinh D, Mattei M-G, Nussbaum J-L, Roussel G, Pontarotti P, Roeckel N, Mather IH, Artzt K, Fisher Lindall K, Dautigny A: Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA 90:7990-7994, 1993 Johns T, Bernard C: The structure and function of myelin oligodendrocyte glycoprotein. J Neurochem 72:1-9, 1999 Pham-Dinh D, Jones E, Pitiot G, Della Gaspera B, Daubas P, Mallet J, Le Paslier D, Fischer LK, Dautigny A: Physical mapping of the human and mouse MOG gene at the distal end of the MHC class Ib region. Immunogenetics 42:386-391, 1995 Lambracht D, Prokop C, Hedrich H, Fischer LK, Wonigeit K: Mapping of H2-M homolog and MOG genes in the rat MHC. Immunogenetics 42:418-421, 1995 Hjelmstrom P, Penzotti J, Henne R, Lybrand T: A molecular model of myelin oligodendrocyte glycoprotein. J Neurochem 71:1742-1749, 1998 Kroepfl J, Viise L, Charron A, Linington C, Gardinier M: Investigation of myelin/oligodendrocyte glycoprotein membrane topology. J Neurochem 67:2219-2222, 1996 Della Gaspera B, Pham-Dinh D, Roussel G, Nussbaum J-L, Dautigny A: Membrane topology of the myelin/oligodendrocyte glycoprotein. Eur J Biochem 258:478-484, 1998 Burger D, Steck AJ, Bernard CCA, Kerlero de Rosbo N: Human myelin/oligodendrocyte glycoprotein: A new member of the L2/HNK-1 family. J Neurochem 61:1822-1827, 1993 Schachner M, Martini R, Hall H, Orberger G: Functions of the L2/HNK-1 carbohydrate in the nervous system. Prog Brain Res 105:183-188, 1995 Quarles R: Glycoproteins of myelin sheaths. J Mol Neurosci 8:1-12, 1997 Dyer C, Matthieu J: Antibodies to myelin/oligodendrocytespecific protein and myelin/oligodendrocyte glycoprotein signal distinct changes in the organization of cultured oligodendroglial membrane sheets. J Neurochem 62:777-787, 1994 Matthieu J, Amiguet P: Myelin/oligodendrocyte glycoprotein expression during development in normal and myelin-deficient mice. Dev Neurosci 12:293-302, 1990 Slavin A, Johns T, Orian J, Bernard C: Regulation of myelin oligodendrocyte glycoprotein in different species throughout development. Dev Neurosci 19:69-78, 1997 Scolding N, Frith S, Linington C, Morgan B, Campbell A, Compston D: Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker for oligodendrocyte maturation. J Neuroimmunol 22:169-176, 1989 Pfeiffer SE, Warrington AE, Bansal R: The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197, 1993 Pribyl T, Campagnoni C, Kampf K, Kashima T, Handley V, McMahon J, Campagnoni A: Expression of the myelin proteolipid protein gene in the human fetal thymus. J Neuroimmunol 67:125-130, 1996 Campagnoni C, Garbay B, Micevych P, Pribyl T, Kampf K, Handley V, Campagnoni A: DM20 mRNA slice product of the myelin protein gene is expressed in the murine heart. J Neurosci Res 33:148-155, 1992 Voskuhl R: Myelin protein expression in lymphoid tissues: Implications for peripheral tolerance. Immunol Rev 164:81-82, 1998 Brunner C, Lassman H, Waehneldt TV, Matthieu JM, Linington C: Differential ultrastructural localization of myelin basic protein, myelin/oligodendroglial glycoprotein, and 2939 cyclic nucleotide phosphodiesterase in the CNS of adult rats. J Neurochem 52:296-304, 1989 Birling M-C, Roussel G, Nussbaum F, Nussbaum J-L: Biochemical and immunohistochemical studies with specific polyclonal antibodies directed against bovine myelin/oligodendrocyte glycoprotein. Neurochem Res 18:937-945, 1993 Mokhtarian F, Zhang Z, Shi Y, Gonzales E, Sobel R: Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol 95:43-54, 1999 Stefferl A, Schubart A, Storch M, Amini A, Mather I, Lassmann H, Linington C: Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. J Immunol 165:2859-2865, 2000 Johns TG, Kerlero de Rosbo N, Menon KK, Abo S, Gonzales MF, Bernard CCA: Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis. J Immunol 154:5536-5541, 1995 Devaux B, Enderlin F, Wallner B, Smilek D: Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide. J Neuroimmunol 75:169-173, 1997 Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu JM, Baker D: Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153:4349-4356, 1994 Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL: Late complications of immune deviation therapy in a non human primate. Science 274:2054-2057, 1996 Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin CW, Lassmann H, Linington C: Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the “resistant” Brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol 163:40-49 1999 Storch MK, Stefferl A, Brehm U, Weissert R, Wallstrom E, Kerschensteiner M, Olsson T, Linington C, Lassmann H: Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8:681-694, 1998 Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL: Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: A new model for multiple sclerosis. Ann Neurol 37:519-530, 1995 Genain CP, Hauser SL: Allergic encephalomyelitis in common marmosets: Pathogenesis of a multiple sclerosis-like lesion. Methods Comp Methods Enzymol 10:420-434, 1996 Genain C, Belmar N, Diaz-Villoslada P, Hauser S: Fine specificities of T cell and B cell responses to myelin/oligodendrocyte glycoprotein in common marmosets. J Neuroimmunol 90:34, 1998 (abstr) Brok H, Uccelli A, Kerlero De Rosbo N, Bontrop R, Roccatagliata L, de Groot N, Capello E, Laman J, Nicolay K, Mancardi G, Ben-Nun A, 't Hart B: Myelin/oligodendrocyte glycoproteininduced autoimmune encephalomyelitis in common marmosets: The encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule. J Immunol 165:1093-1101, 2000 Antunes S, de Groot N, Brok H, Doxiadis G, Menezes A, Otting N, Bontrop R: The common marmoset: a new world primate species with limited Mhc class II variability. Proc Natl Acad Sci USA 95:11745-11750, 1998 Kerlero de Rosbo N, Brok H, Bauer J, Kaye J, 'tHart B, Ben Nun A: Rhesus monkeys are highly susceptible to experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein: Characterization of immunodominant T and B cell epitopes. J Neuroimmunol 110:83-96, 2000 Kerlero de Rosbo N, Hoffman M, Mendel I, Yust I, Kaye J, Bakimer R, Flechter S, Abramsky O, Milo R, Karni A, Ben-Nun A: Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions. Eur J Immunol 27:3059-3069, 1997 Mendel I, Kerlero de Rosbo N, Ben-Nun A: A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor Vβ expression of encephalitogenic T cells. Eur J Immunol 25:1951-1959, 1995 Mendel I, Kerlero de Rosbo N, Ben-Nun A: Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: Diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice. Eur J Immunol 26:2470-2479, 1996 Kerlero de Rosbo N, Mendel I, Ben-Nun A: Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide. Eur J Immunol 25:985-993, 1995 Bernard C, Johns T, Slavin A, Ichikawa M, Ewing C, Liu J, Bettadapura J: Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis. J Mol Med 75:77-88, 1997 Ichikawa M, Johns TG, Liu J, Bernard CCA: Analysis of the fine B-cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55. J Immunol 157:919-926, 1996 Tsunoda I, Kuang L, Theil D, Fujinami R: Antibody association with a novel model for primary progressive multiple sclerosis: Induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain pathol 10:402-418, 2000 Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu J, Gardinier M, Dornmair K, Linington C: The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat. J Neuroimmunol 63:17-27, 1995 Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H: Experimental autoimmune encephalomyelitis: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab Invest 76:355-364, 1997 Weissert R, Wallstrom E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, Linington C, Olsson T: MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102:1265-1273, 1998 Juedes AE, Hjelmstrom P, Bergman CM, Neild AL, Ruddle NH: Kinetics and cellular origin of cytokines in the central nervous system: Insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 164:419-426, 2000 Schluesener HJ, Sobel RA, Linington C, Weiner HL: A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol 139:4016-4021, 1987 Litzenburger T, Fassler R, Bauer J, Lassmann H, Linington C, Wekerle H, Iglesias J: B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med 188:169-180, 1998 Hjelmstrom P, Juedes A, Fjell J, Ruddle N: Cutting Edge: B cell deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 161:4480-4483, 1998 Lyons J, San M, Happ M, Cross A: B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 29:3432-3439, 1999 Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ: A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp Med 189:1639-48, 1999. Dahlman I, Wallstrom E, Weissert R, Storch M, Kornek B, Jacobsson L, Linington C, Luthman H, Lassmann H, Olsson T: Linkage analysis of myelin oligodendrocyte glycoproteininduced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum Mol Genet 8:2183-2190, 1999 Olsson T, Dahlman I, Wallstrom E, Weissert R, Piehl F: Genetics of rat neuroinflammation. J Neuroimmunol 107:191-200, 2000 McFarland H, Lobito A, Johnson M, Nyswaner J, Frank J, Palardy G, Tresser N, Genain C, Mueller J, Matis L, Lenardo M: Determinant spreading associated with demyelination in a nonhuman primate model of multiple sclerosis. J Immunol 162: 2384-2390, 1999 Genain CP, Lee-Parritz D, Nguyen MH, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL: In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J Clin Invest 94:1339-1345, 1994 Villoslada P, Abel K, Heald N, Goertsches R, Hauser S, Genain C: Repertoire heterogeneity, encephalitogenicity and evidence for regulatory control of precursor T cells specific for myelin oligodendrocyte glycoprotein in naive populations of outbred primates (submitted for publication) von Büdingen H-C, Hauser S, Genain C: Molecular analysis of the antibody response against myelin oligodendrocyte glycoprotein in primate experimental autoimmune encephalomyelitis. Ann Neurol 48:A416, 2000 Brehm U, Piddlesden S, Gardinier M, Linington C: Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein (MOG). J Neuroimmunol 97:9-15, 1999. Ouallet J-C, Heald N, Islar J, Hauser S, Genain C: Detection of B-cells specific for the autoantigen myelin/oligodendrocyte glycoprotein using a sensitive immunogold-labeling assay. Neurology 52(Suppl 2):A337, 1999 Reindl M, Linington C, Brehm U, Egg R, Dilitz E, Deisenhammer F, Poewe W, Berger T: Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study. Brain 122:2047-2056, 1999 Litzenburger T, Blu¨thmann H, Morales P, Pham-Dinh D, Dautigny A, Wekerle H, Iglesias A: Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: Receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein. J Immunol 165: 5360-5366, 2000 Wucherpfennig KW, Strominger JL: Molecular mimicry in T cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80:695-705, 1995 Amiguet P, Gardinier MV, Zanetta JP, Matthieu JM: Purification and partial structural and functional characterization of mouse myelin/oligodendrocyte glycoprotein. J Neurochem 58:1676-1682, 1992 Abo S, Bernard C, Webb M, Johns T, Alafaci A, Ward L, Simpson R, Kerlero de Rosbo N: Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities suffi-cient for encephalitogenicity and immunogenicity studies. Biochem Mol Biol Int 30:945-958, 1993 Pham-Dinh D, Della Gaspera B, Kerlero de Rosbo N, Dautigny A: Sructure of the human myelin/oligodendrocyte glycoprotein gene and multiple alternative spliced isoforms. Genomics 29: 345-352, 1995 Ballenthin P, Gardinier M: Myelin/oligodendrocyte glycoprotein is alternatively spliced in humans but not mice. J Neurosci Res 46:271-281, 1996 Bettadapura J, Menon K, Moritz S, Liu J, Bernard C: Expression, purification, and encephalitogenicity of recombinant human myelin oligodendrocyte glycoprotein. J Neurochem 70:1593-1599, 1998 Abdul-Majid K, Jirholt J, Stadelmann C, Stefferl A, Kjellen P, Wallstrom E, Holmdahl R, Lassmann H, Olsson T, Harris RA: Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J Neuroimmunol 111:23-33, 2000 Genain CP, Hauser SL: Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 75:187-197, 1997 Slavin A, Ewing C, Liu J, Ichikawa M, Slavin J, Bernard C: Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity 28:109-120, 1998